Delivery Order SPE2DB20D2014-SPE2DB25FC31T
- Not listed
- This is a $13,926.61 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Orencia Clickject 125 mg/ml, a pharmaceutical product, with a period of performance through June 18, 2025. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides comprehensive global...
- This federal contract award, valued at $3,640.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Orencia Clickject 125 mg/ml, a pharmaceutical product. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 28, 2025. The contract is not set-aside and is open to competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award, valued at $30,761.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Orencia Clickject 125 mg/ml, with a performance period through April 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,650.91, is for the supply of Orencia ClickJect 125 mg/mL, a specialty pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $6,776.20 fixed-price delivery order is for ORENCIA CLICKJECT 125 MG/MLML, a pharmaceutical product. The contract has an ultimate completion date of March 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $5,762.12 firm fixed-price delivery order is for the supply of ORENCIA CLICKJECT 125 MG/ML, a prescription medication. The contract has an ultimate completion date of June 26, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, valued at $7,687.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Orencia Clickject 125 mg/ml, a pharmaceutical product, with a performance period that extends through April 2025. The contract is designated as a delivery order and utilizes a firm-fixed-price pricing type. It is not associated with a set-aside program....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $45,958.10, is for the supply of Orencia ClickJect 125 mg/mL injections. The contract has a performance period through May 21, 2025 and is not set aside for any small business program. AmerisourceBergen is a critical supplier of pharmaceutical and medical products to various federal...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation. The contract is for the delivery of Orencia Clickject 125 mg/mL, a pharmaceutical product, with a potential value of $3,331.92 and a performance period ending on March 8, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp, as the prime contractor, is the sole awardee on...
- This federal contract award, valued at $6,923.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Orencia Clickject 125 mg/ml, a medication, with a completion date of March 27, 2025. This contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC31TDelivery Order
This is a $3,594.04 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the drug Orencia Clickject 125 mg/mL and has a completion date of June 27, 2025. Amerisourcebergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract award is not designated as a set-aside. Amerisourcebergen, as the prime contractor, has no listed major subcontractors for this delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 6/26/25 |